Inhaler
11446451 · 2022-09-20
Assignee
Inventors
- Donald SMITH (Edinburgh, GB)
- Gregor John McLennan ANDERSON (London, GB)
- Lisa Charleston MCMYN (West Linton, GB)
- Alan Miller SUTTIE (Glasgow, GB)
Cpc classification
A61M15/0028
HUMAN NECESSITIES
A61M15/0061
HUMAN NECESSITIES
A61M11/003
HUMAN NECESSITIES
A61M15/0043
HUMAN NECESSITIES
International classification
Abstract
A device for inhaling an active agent is provided that can be moved from a first configuration to a second configuration. The device comprises two flexible substrates and a membrane located between the two flexible substrates, and the two flexible substrates being connected at two opposing edges and unconnected at two further opposing edges. An active agent provided on the membrane may be inhaled by a user when the device is in the second configuration. A method of using the device is also provided.
Claims
1. A device comprising two flexible substrates and a membrane located between the two flexible substrates, the two flexible substrates being connected at two opposing edges and unconnected at a first end having a first opening with two further opposing edges and a second end having a second opening with two further opposing edges, wherein the device is configured to move between a first configuration where the two flexible substrates are substantially flat and the opposing edges defining the first opening are in contact with one another and the opposing edges defining the second opening are in contact with one other, and a second configuration where the two flexible substrates are flexed and the opposing edges defining the first opening are not in contact with one other and the opposing edges defining the second opening are not in contact with one other such that a channel is formed between the two flexible substrates, wherein the membrane is configured to span the channel between the two flexible substrates when the device is in the second configuration, such that an active agent provided on the membrane may be inhaled by a user when the device is in the second configuration, and wherein each of the two flexible substrates comprises a reinforcing element which are parallel to each other in the first configuration, and wherein each reinforcing element biases the device toward the second configuration.
2. The device according to claim 1, wherein the two flexible substrates are rectangular, square or oblong.
3. The device according to claim 1, wherein the two flexible substrates are biodegradable.
4. The device according to claim 1, wherein at least a portion of one or both of the two flexible substrates comprises a metallic coating.
5. The device according to claim 1, wherein the cross-section of the channel is reduced in a portion of the channel.
6. The device according to claim 1 comprising a seal at either side of the membrane.
7. The device according to claim 6, wherein the seals are adjacent to the openings of the channel.
8. The device according to claim 6, wherein the seals are adjacent to the membrane.
9. The device according to claim 1, wherein each reinforcing element is adjacent to one or both openings of the channel.
10. The device according to claim 1, wherein each reinforcing element is a strip of material that is stiffer than the flexible substrates.
11. The device according to claim 1, wherein the membrane is a mesh.
12. The device according to claim 1, wherein the membrane is air permeable.
13. The device according to claim 1, wherein the membrane is mounted to both flexible substrates.
14. The device according to claim 1, wherein the membrane is flexible and is folded or collapsed when the device is in the first configuration.
15. The device according to claim 1, wherein the active agent is present on the membrane.
16. The device according to claim 15, wherein the active agent is in particulate form.
17. The device according to claim 1, wherein the active agent is an inhalable active agent selected from the group: tramadol, gabapentin, Vicodin (registered trademark), ibuprofen, acetaminophen, hydrocodone, naproxen, methadone, codeine, hydroxyzine, paracetamol, aspirin, insulin, canagliflozin, alogliptin benzoate, dapaglifozin, empagliflozin, ranibizumab, duglaglutide, pioglitazone hydrochloride, glimepiride, oxytocin, and sildenafil.
18. A method of using a device according to claim 1, the method comprising the steps: (i) providing a device according to claim 1; (ii) applying pressure to the two opposed connected edges of the two flexible substrates of the device to thereby move the device from the first, closed configuration, to the second, open configuration; and (iii) inhaling adjacent to an opening of the device in the second configuration to thereby inhale the active agent from the membrane of the device through the channel and into the lungs.
19. The method according to claim 18, wherein the user contacts their lips to an opening of the device in the second configuration to thereby form a seal around that opening before inhaling the active agent.
20. The device according to claim 1, wherein each reinforcing element are in contact with one another in the first configuration.
Description
BRIEF DESCRIPTION OF THE FIGURES
(1) Embodiments of the present invention will now be described, by way of non-limiting example, with reference to the accompanying drawings.
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
DETAILED DESCRIPTION
(20) While the making and using of various embodiments of the present invention are discussed in detail below, it should be appreciated that the present invention provides many applicable inventive concepts that can be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the invention and do not delimit the scope of the invention.
(21) To facilitate the understanding of this invention, a number of terms are defined below. Terms defined herein have meanings as commonly understood by a person of ordinary skill in the areas relevant to the present invention. Terms such as “a”, “an” and “the” are not intended to refer to only a singular entity, but include the general class of which a specific example may be used for illustration. The terminology herein is used to describe specific embodiments of the invention, but their usage does not delimit the invention, except as outlined in the claims.
(22) With reference to
(23) The inhaler is configured to move between two configurations, a closed configuration as shown in
(24) The inhaler is retained before use in a sealed water proof envelope to ensure that the salbutamol on the mesh does not come into contact with water.
(25) When the inhaler is to be used, the inhaler is removed from the water proof envelope. The user pinches the two sides of the inhaler that are connected together to move the inhaler from the closed configuration to the open configuration (see
(26) In an alternative embodiment, with reference to
(27) With reference to
(28) When the device is moved from the first configuration to the second configuration, the seals 110, 112 are broken and the membrane 106 is exposed for use.
(29) In a further alternative embodiment, with reference to
(30) Accordingly, the reinforcing strips assist the user to open the device by moving the device from the closed configuration to the open configuration.
(31) In a yet further embodiment, the two card sheets comprise creases (not shown) acting as flexible regions that bias the device towards the open configuration. Accordingly, the device may more readily open when pressure is applied to the connected opposing edges by the user.
(32) In another embodiment, the mesh comprises particles that comprise an inhalable form of insulin as the active agent.
(33) With reference to
(34) In a first configuration (shown in
(35) With reference to
(36) A variation of the device shown in
(37) A similar effect may be achieved by devices with channels that narrow to an aperture such as those shown in
(38) A membrane 402 mounted in a support 404 is shown in
(39) It will be appreciated by the person skilled in the art that the above embodiments are examples and that the features of each disclosed embodiment may be combined with the features of other embodiments. Further variations and modifications are herein contemplated and included in the present invention.